Our results revealed that GCIP expression was significantly downregulated in NSCLC tissues, and the antitumor activity of GCIP was mechanistically mediated by the ability of GCIP not only to interact with Id1 but also to suppress its transcriptional activity, and thereby, increasing the susceptibility to chemotherapeutic agents. This evidence concerns the gene CCNDBP1 and non-small cell lung carcinoma.